{"id":62188,"date":"2025-11-12T01:03:21","date_gmt":"2025-11-12T00:03:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/"},"modified":"2025-11-12T01:03:21","modified_gmt":"2025-11-12T00:03:21","slug":"correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/","title":{"rendered":"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment"},"content":{"rendered":"<div>\n<p>\n\u00a0<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/5\/Rion_Primary.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/22\/Rion_Primary.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/5\/Rion_Primary.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/21\/Rion_Primary.jpg\"><\/a><\/p>\n<p>ROCHESTER, Minn.&#8211;(BUSINESS WIRE)&#8211;Please replace the release with the following corrected version due to multiple revisions.<\/p>\n<p>\nThe updated release reads:<\/p>\n<p>\n<b>RION LAUNCHES RION VET TO TRANSFORM ANIMAL HEALTH WITH FIRST-IN-CLASS BIOLOGIC THERAPEUTIC; APPOINTS INDUSTRY LEADER MARK HERTHEL AS CEO; ANNOUNCES SERIES A FULFILLMENT<\/b><\/p>\n<p>\nRION, a clinical-stage regenerative medicine company and global leader in exosome-based therapeutics, today announced the formation of RION Vet, a veterinary biotechnology company advancing a pioneering first-in-class platelet-derived biologic therapeutic to address major unmet needs in animal health. RION Vet has the exclusive global rights to RION\u2019s proprietary therapeutic platform for veterinary use. In contrast to whole cell therapeutics, RION Vet\u2019s first product (ePEP-01) is a cell-free shelf-stable biologic derived from platelets, which are instrumental in tissue repair and regeneration. ePEP-01 is under rapid development for equine musculoskeletal indications based on nearly 5 years of consistent results in equine clinical studies.<\/p>\n<p>\nRION Vet has appointed Mark Herthel as Chief Executive Officer. Mr. Herthel is co-founder and former CEO of Platinum Performance (acquired by Zoetis) and owner of Alamo Pintado Equine Medical Center, one of the world\u2019s foremost centers for equine innovation. Mr. Herthel also led RION Vet\u2019s recently completed $15M Series A financing, anchoring the raise as its lead investor.<\/p>\n<p>\n\u201cRION Vet is the natural next step in our mission to drive the regenerative medicine revolution,\u201d said Atta Behfar, M.D., Ph.D., Co-Founder of RION. \u201cThis dedicated animal health company will bring decades of exosome science and biomanufacturing expertise straight to veterinarians and animal owners worldwide. With a veterinary industry leader like Mark Herthel, RION Vet blends breakthrough science with proven veterinary innovation to deliver the next generation of biologics.\u201d<\/p>\n<p>\n\u201cRION Vet is uniquely positioned to redefine standards of veterinary care with its\u2019 therapeutic biologics that deliver consistent, convenient, and scalable therapies,\u201d said Mark Herthel, CEO of RION Vet. \u201cOur lead candidate, ePEP-01, has been evaluated in more than four years of studies in over 50 horses, showing meaningful improvements in lameness with a strong safety profile. We look forward to presenting the clinical data at upcoming veterinary scientific meetings. With expansion into canine musculoskeletal disease and dermatitis, we are building a broad pipeline with the potential to transform multiple high-value animal health markets.\u201d<\/p>\n<p>\nRION Vet will leverage RION\u2019s industry-leading biomanufacturing platform to develop cell-free biological therapeutics based on more than two decades of Mayo Clinic research. RION Vet will take advantage of RION\u2019s platform for the production of ePEP-01 and future products at scale. Beyond equine musculoskeletal disease, the company is advancing programs in canine musculoskeletal disease, atopic dermatitis, wound healing, ocular, respiratory, and cardiac conditions, unlocking an estimated $8\u201312B global market opportunity.<\/p>\n<p>\n<b>About RION Vet<\/b><\/p>\n<p>\nRION Vet is a clinical-stage veterinary biotechnology company pioneering first-in-class platelet-derived therapeutics for use in animals. Spun out of RION and built on more than two decades of Mayo Clinic research, RION Vet\u2019s lead program, ePEP-01, is being developed under the purview of the FDA\u2019s Center for Veterinary Medicine for equine musculoskeletal disease. RION Vet is also advancing programs in canine musculoskeletal disease and dermatitis, with pipeline opportunities spanning wound, ocular, respiratory, and cardiac indications.<\/p>\n<p>\n<b>About RION<\/b><\/p>\n<p>\nRION is a clinical-stage regenerative medicine company founded out of the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program after two decades of stem cell and exosome research and innovation. RION is a global leader in isolating and mass-producing platelet-derived regenerative exosomes into a proprietary therapeutic platform to produce Purified Exosome Product (PEP), a shelf-stable biologic designed to activate the body\u2019s natural healing processes. RION is advancing an ambitious pipeline with clinical and preclinical programs in advanced wound care, immune-mediated dermatology, musculoskeletal injury, pulmonary disease, cardiovascular health, and women\u2019s health. RION\u2019s regenerative PEP technology will be integral to the therapeutic exosome revolution.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nScott McCrea at <a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#115;&#109;&#99;&#99;&#x72;&#x65;&#x61;&#x40;&#x72;&#x69;&#x6f;&#x6e;&#x74;x&#46;co&#109;\" rel=\"nofollow\" shape=\"rect\">&#115;m&#x63;c&#x72;e&#x61;&#64;&#x72;&#105;&#x6f;&#110;t&#x78;&#46;&#x63;o&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 ROCHESTER, Minn.&#8211;(BUSINESS WIRE)&#8211;Please replace the release with the following corrected version due to multiple revisions. The updated release reads: RION LAUNCHES RION VET TO TRANSFORM ANIMAL HEALTH WITH FIRST-IN-CLASS BIOLOGIC THERAPEUTIC; APPOINTS INDUSTRY LEADER MARK HERTHEL AS CEO; ANNOUNCES SERIES A FULFILLMENT RION, a clinical-stage regenerative medicine company and global leader in exosome-based therapeutics, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62188","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u00a0 ROCHESTER, Minn.&#8211;(BUSINESS WIRE)&#8211;Please replace the release with the following corrected version due to multiple revisions. The updated release reads: RION LAUNCHES RION VET TO TRANSFORM ANIMAL HEALTH WITH FIRST-IN-CLASS BIOLOGIC THERAPEUTIC; APPOINTS INDUSTRY LEADER MARK HERTHEL AS CEO; ANNOUNCES SERIES A FULFILLMENT RION, a clinical-stage regenerative medicine company and global leader in exosome-based therapeutics, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-12T00:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/22\/Rion_Primary.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment\",\"datePublished\":\"2025-11-12T00:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/\"},\"wordCount\":664,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251111624107\\\/en\\\/1695379\\\/22\\\/Rion_Primary.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/\",\"name\":\"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251111624107\\\/en\\\/1695379\\\/22\\\/Rion_Primary.jpg\",\"datePublished\":\"2025-11-12T00:03:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251111624107\\\/en\\\/1695379\\\/22\\\/Rion_Primary.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251111624107\\\/en\\\/1695379\\\/22\\\/Rion_Primary.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/","og_locale":"en_US","og_type":"article","og_title":"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment - Pharma Trend","og_description":"\u00a0 ROCHESTER, Minn.&#8211;(BUSINESS WIRE)&#8211;Please replace the release with the following corrected version due to multiple revisions. The updated release reads: RION LAUNCHES RION VET TO TRANSFORM ANIMAL HEALTH WITH FIRST-IN-CLASS BIOLOGIC THERAPEUTIC; APPOINTS INDUSTRY LEADER MARK HERTHEL AS CEO; ANNOUNCES SERIES A FULFILLMENT RION, a clinical-stage regenerative medicine company and global leader in exosome-based therapeutics, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-12T00:03:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/22\/Rion_Primary.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment","datePublished":"2025-11-12T00:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/"},"wordCount":664,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/22\/Rion_Primary.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/","url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/","name":"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/22\/Rion_Primary.jpg","datePublished":"2025-11-12T00:03:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/22\/Rion_Primary.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251111624107\/en\/1695379\/22\/Rion_Primary.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-rion-launches-rion-vet-to-transform-animal-health-with-first-in-class-biologic-therapeutic-appoints-industry-leader-mark-herthel-as-ceo-announces-series-a-fulfillment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62188"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62188\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}